arrow
M

Michal Mego

national institute of oncology
H指数:44
被引数:6,164

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic targeting of folate receptor alpha (FRα) by antibody-polymer-drug conjugate in testicular germ cell tumors

抗体-聚合物-药物偶联物靶向治疗睾丸生殖细胞肿瘤中的叶酸受体α(FRα)

2026-08-080
OA
Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study

生殖细胞肿瘤早期死亡的风险因素和原因:一项全球罕见泌尿生殖系统肿瘤学会研究

2026-06-020
OAAI
Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer
2026-02-030
OAAI
Prognostic Value of Neutrophil-to-Lymphocyte Ratio Across Barcelona Clinic Liver Cancer Stages in Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

中性粒细胞与淋巴细胞比值在巴塞罗那临床肝癌分期中的预后价值:一项多中心回顾性分析

2026-02-010
OAAI
Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves (Leverages) cisplatin treatment efficacy

血浆DNase水平较低与睾丸生殖细胞肿瘤患者的较差临床结局相关,外源性DNase I可增强(利用)顺铂的治疗效果。

2025-12-041
PRE
Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma

胎盘间充质干细胞:促进胰腺导管腺癌基因治疗的有前景的平台

2025-08-060
PRE
The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group
2024-07-221
OAAI